Dubai Telegraph - 'Whole family cried': New gene therapy offers hope for deaf kids

EUR -
AED 4.100113
AFN 77.023391
ALL 99.447336
AMD 432.838798
ANG 2.014767
AOA 1036.468947
ARS 1074.711254
AUD 1.636359
AWG 2.00931
AZN 1.92827
BAM 1.957305
BBD 2.257155
BDT 133.59389
BGN 1.965384
BHD 0.42068
BIF 3230.523246
BMD 1.116283
BND 1.443523
BOB 7.725007
BRL 6.061866
BSD 1.117969
BTN 93.496501
BWP 14.707659
BYN 3.658545
BYR 21879.148453
BZD 2.253342
CAD 1.512678
CDF 3204.849171
CHF 0.945843
CLF 0.037658
CLP 1039.103456
CNY 7.8899
CNH 7.892758
COP 4648.481834
CRC 579.080293
CUC 1.116283
CUP 29.581502
CVE 110.791537
CZK 25.09505
DJF 198.385833
DKK 7.459342
DOP 67.201269
DZD 147.957368
EGP 54.174306
ERN 16.744246
ETB 128.657351
FJD 2.453423
FKP 0.850115
GBP 0.840299
GEL 3.047465
GGP 0.850115
GHS 17.524653
GIP 0.850115
GMD 76.468857
GNF 9658.645645
GTQ 8.64172
GYD 233.81355
HKD 8.700707
HNL 27.731566
HRK 7.589621
HTG 147.324568
HUF 394.065769
IDR 16940.712088
ILS 4.213405
IMP 0.850115
INR 93.347554
IQD 1462.33084
IRR 46987.14472
ISK 152.305694
JEP 0.850115
JMD 175.63501
JOD 0.791107
JPY 159.436514
KES 144.00081
KGS 94.074773
KHR 4543.271796
KMF 492.672047
KPW 1004.654143
KRW 1482.736164
KWD 0.3404
KYD 0.931512
KZT 535.361582
LAK 24653.111884
LBP 100018.964577
LKR 340.294632
LRD 216.83831
LSL 19.529721
LTL 3.296094
LVL 0.675228
LYD 5.325093
MAD 10.841334
MDL 19.50581
MGA 5036.894411
MKD 61.664335
MMK 3625.643914
MNT 3793.12987
MOP 8.973393
MRU 44.333165
MUR 51.204203
MVR 17.14598
MWK 1937.867679
MXN 21.522362
MYR 4.699547
MZN 71.274774
NAD 19.535528
NGN 1831.060868
NIO 41.137015
NOK 11.702609
NPR 149.612347
NZD 1.786209
OMR 0.429724
PAB 1.117969
PEN 4.180462
PGK 4.438412
PHP 62.045802
PKR 310.92129
PLN 4.272947
PYG 8726.786438
QAR 4.075633
RON 4.974608
RSD 117.069099
RUB 102.892984
RWF 1505.388617
SAR 4.18887
SBD 9.288327
SCR 15.203375
SDG 671.44267
SEK 11.337749
SGD 1.441813
SHP 0.850115
SLE 25.504058
SLL 23407.892397
SOS 638.896842
SRD 33.324404
STD 23104.806079
SVC 9.781519
SYP 2804.694667
SZL 19.535619
THB 37.004871
TJS 11.882003
TMT 3.906991
TND 3.375641
TOP 2.623048
TRY 37.953999
TTD 7.59799
TWD 35.642385
TZS 3041.24574
UAH 46.326211
UGX 4151.228228
USD 1.116283
UYU 45.925303
UZS 14242.075436
VEF 4043794.116249
VES 40.994414
VND 27438.238213
VUV 132.52737
WST 3.12276
XAF 656.485163
XAG 0.03591
XAU 0.000431
XCD 3.016811
XDR 0.828544
XOF 656.461621
XPF 119.331742
YER 279.433556
ZAR 19.537637
ZMK 10047.88601
ZMW 29.093234
ZWL 359.442698
  • RIO

    2.1500

    65.06

    +3.3%

  • CMSC

    -0.0050

    25.05

    -0.02%

  • SCS

    -0.9100

    13.2

    -6.89%

  • BTI

    -0.2750

    37.605

    -0.73%

  • NGG

    -1.2250

    68.825

    -1.78%

  • CMSD

    0.0400

    25.02

    +0.16%

  • AZN

    0.4350

    79.015

    +0.55%

  • RBGPF

    3.5000

    60.5

    +5.79%

  • BP

    0.4200

    32.85

    +1.28%

  • GSK

    -0.6250

    41.805

    -1.5%

  • RYCEF

    0.4000

    6.95

    +5.76%

  • BCE

    -0.3710

    35.239

    -1.05%

  • VOD

    -0.1700

    10.06

    -1.69%

  • BCC

    6.0200

    143.08

    +4.21%

  • JRI

    -0.0500

    13.39

    -0.37%

  • RELX

    0.6900

    48.06

    +1.44%

'Whole family cried': New gene therapy offers hope for deaf kids
'Whole family cried': New gene therapy offers hope for deaf kids / Photo: Handout - Eye & Ent Hospital of Fudan University/AFP

'Whole family cried': New gene therapy offers hope for deaf kids

Zhu Yangyang babbles away like a typical happy three-year-old, calling out for "mama" and "papa" and accurately naming colors -- a remarkable achievement considering he was completely deaf just months ago.

Text size:

He is one of five children whose hearing was restored through a revolutionary new gene therapy in a clinical trial led by Chinese and American researchers, offering new hope for those born with a rare genetic mutation.

Yangyang's mother Chang Yiyi says she was moved to tears when she realized, around three weeks after the treatment last September, that Yangyang could hear her knocking on the door.

"I hid in a closet and called for him, and he still responded!" she told AFP in an interview from Shanghai.

The results of the study, published Wednesday in the prestigious journal Nature Medicine, mark the first time the procedure was performed on both ears. This led to significant improvements in speech perception and the ability to locate the source of sounds compared to treatment in just one ear.

"This is absolutely a turning point," Zheng-Yi Chen, the study's senior author at the Eaton-Peabody Laboratories at Mass Eye and Ear, told AFP, adding companies are now conducting clinical trials, including two in Boston, with the goal of moving towards regulatory approval.

"If the results hold, without any complications, I think in three to five years, it may be a medically approved product," he added.

- Rare mutation -

There are around 26 million people globally with genetic forms of deafness, with this particular therapy focusing on people born with a mutation of the OTOF gene -- roughly two to eight percent of inherited deafness cases.

This defect means they are unable to produce the protein otoferlin, which is needed for hair cells in the inner ear to convert sound vibrations into electrical signals that can be sent to the brain.

The treatment involves injecting a modified virus into the inner ear that smuggles in a working version of the OTOF gene, restoring hearing.

When they realized that Yangyang could hear for the first time, "the whole family cried" including Yangyang's mother and grandmother, said lead study author Yilai Shu of the Eye & ENT Hospital of Fudan University in Shanghai.

Chang, a 26-year-old homemaker, said that taking care of her son has become much easier since he began developing language skills, and the family soon hopes to move him from a speech rehabilitation school to traditional kindergarten.

- More genetic targets -

Shu led the research team that delivered the very first OTOF gene therapy in 2022, pioneering a treatment that has since been administered to more children around the world, including in the United States and the United Kingdom.

Treating both ears presented new challenges, he told AFP. Doubling the surgical procedures increased the risk of side effects.

However, careful dosing minimized the immune response, and only mild to moderate side effects -- like fever, vomiting and slightly elevated white cell counts -- were observed.

All five children, who ranged in age from one to 11, saw major improvements.

Two of them gained an ability to appreciate music -- a more complex acoustic signal -- and danced happily in videos recorded for the study.

Surprisingly, even the 11-year-old has gained some capacity to understand speech and talk, even though it was expected it would be too late for the brain to acquire this ability if it had never before perceived sound.

"That really shows our brain has a plasticity that maybe lasts much longer than we originally thought," said Chen. The clinical trial is ongoing, and the participants will be monitored for long-term follow up.

Meanwhile, Shu and Chen said they are working on further animal testing to develop treatments for other causes of genetic deafness, including those related to the GJB2 gene -- the most common cause of deafness present at birth.

F.Chaudhary--DT